Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients

Blanca Xicoy, Josep-Maria Ribera, Markus Müller, Olga García, Christian Hoffmann, Albert Oriol, Marcus Hentrich, Carlos Grande, Jan-Christian Wasmuth, Jordi Esteve, Jan van Lunzen, Eloy del Potro, Heribert Knechten, Salut Brunet, Christoph Mayr, Lourdes Escoda, Philipp Schommers, Natalia Alonso, Ferran Vall-llovera, Montserrat Pérez, Mireia Morgades, José González, Angeles Fernández, Jan Thoden, Nicola Gökbuget, Dieter Hoelzer, Gerd Fätkenheuer, Christoph Wyen
  • Leukemia & Lymphoma, February 2014, Taylor & Francis
  • DOI: 10.3109/10428194.2013.878933
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.3109/10428194.2013.878933

The following have contributed to this page: Dr Albert Oriol